Prechemoradiotherapy Systemic Inflammation Response Index Stratifies Stage IIIB/C Non-Small-Cell Lung Cancer Patients into Three Prognostic Groups: A Propensity Score-Matching Analysis

PURPOSE: We explored the prognostic influence of the systemic inflammation response index (SIRI) on the survival outcomes of stage IIIB/C non-small-cell lung cancer (NSCLC) patients who underwent concurrent chemoradiotherapy. METHODS: Present propensity score-matching (PSM) analysis comprised 876 st...

Descripción completa

Detalles Bibliográficos
Autores principales: Topkan, Erkan, Selek, Ugur, Kucuk, Ahmet, Haksoyler, Veysel, Ozdemir, Yurday, Sezen, Duygu, Mertsoylu, Huseyin, Besen, Ali Ayberk, Bolukbasi, Yasemin, Ozyilkan, Ozgur, Pehlivan, Berrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847338/
https://www.ncbi.nlm.nih.gov/pubmed/33552158
http://dx.doi.org/10.1155/2021/6688138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847338/
https://www.ncbi.nlm.nih.gov/pubmed/33552158
http://dx.doi.org/10.1155/2021/6688138

Ejemplares similares